{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:05:11Z","timestamp":1793225111553,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.vaccine.2013.02.029","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T02:12:00Z","timestamp":1377223920000},"page":"D52-D57","source":"Crossref","is-referenced-by-count":123,"special_numbering":"S4","title":["Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants"],"prefix":"10.1016","volume":"31","author":[{"given":"Shabir A.","family":"Madhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyaad","family":"Dangor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaine","family":"Izu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoke","family":"Sobanjo-ter Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Dull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9832","key":"10.1016\/j.vaccine.2013.02.029_bib0005","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.029_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cid\/cis395","article-title":"Variation in reported neonatal group B streptococcal disease incidence in developing countries","volume":"55","author":"Dagnew","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9815","key":"10.1016\/j.vaccine.2013.02.029_bib0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.029_bib0020","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1542\/peds.2011-1548","article-title":"Maternal HIV infection and vertical transmission of pathogenic bacteria","volume":"130","author":"Cutland","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.029_bib0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3201\/eid1302.060680","article-title":"Invasive group B streptococcal infection in infants, Malawi","volume":"13","author":"Gray","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.029_bib0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa040275","article-title":"Bacteremia among children admitted to a rural hospital in Kenya","volume":"352","author":"Berkley","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.029_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM200001063420103","article-title":"Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis","volume":"342","author":"Schrag","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.02.029_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","author":"Schrag","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.02.029_bib0045","unstructured":"Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010, 59(RR-10):1-36."},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.029_bib0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1651-2227.2005.tb01917.x","article-title":"Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention","volume":"94","author":"Lopez Sastre","year":"2005","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.029_bib0055","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.pcl.2009.04.003","article-title":"Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis","volume":"56","author":"Koenig","year":"2009","journal-title":"Pediatr Clin North Am"},{"issue":"11","key":"10.1016\/j.vaccine.2013.02.029_bib0060","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/INF.0b013e318223bad2","article-title":"The burden of invasive early-onset neonatal sepsis in the United States, 2005\u20132008","volume":"30","author":"Weston","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.029_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017155","article-title":"Where do poor women in developing countries give birth? A multi-country analysis of demographic and health survey data","volume":"6","author":"Montagu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.02.029_bib0070","unstructured":"World Health Organisation. www.who.int\/immunization_monitoring\/diseases\/\u2026\/en\/index.html. Accessed 5 Jan 2013."},{"issue":"15","key":"10.1016\/j.vaccine.2013.02.029_bib0075","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.029_bib0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1503\/cmaj.110754","article-title":"Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial","volume":"184","author":"Steinhoff","year":"2012","journal-title":"Can Med Assoc J"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.02.029_bib0085","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajog.2012.06.071","article-title":"A review of fetal and infant protection associated with antenatal influenza immunization","volume":"207","author":"Steinhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.029_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000441","article-title":"Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study","volume":"8","author":"Omer","year":"2011","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.vaccine.2013.02.029_bib0095","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1172\/JCI119042","article-title":"Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine","volume":"98","author":"Kasper","year":"1996","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.029_bib0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/erv.11.61","article-title":"An update on vaccination against group B streptococcus","volume":"10","author":"Heath","year":"2011","journal-title":"Exp Rev Vacc"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.029_bib0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1086\/375536","article-title":"Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III","volume":"188","author":"Baker","year":"2003","journal-title":"J Infect Dis"},{"issue":"9405","key":"10.1016\/j.vaccine.2013.02.029_bib0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(03)15389-5","article-title":"Group B streptococcal disease in UK and Irish infants younger than 90 days","volume":"363","author":"Heath","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.029_bib0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF00445584","article-title":"Correlation between serum antibody-levels against group B streptococci and gestational age in newborns","volume":"142","author":"Christensen","year":"1984","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.029_bib0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/000349803125002814","article-title":"High burden of invasive Streptococcus agalactiae disease in South African infants","volume":"23","author":"Madhi","year":"2003","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2013.02.029_bib0125","series-title":"52nd Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Multi-center Study of the Burden of Invasive Neonatal and Early Infant Group B Streptococcal Disease","author":"Rivera","year":"2012"},{"issue":"19","key":"10.1016\/j.vaccine.2013.02.029_bib0130","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2012.54092","article-title":"ACIP. Give pertussis vaccine during every pregnancy","volume":"308","author":"Kuehn","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2013.02.029_bib0135","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 521: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet. Gynecol. 2012, 119(3):690\u2013691.","DOI":"10.1097\/AOG.0b013e31824e1327"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2013.02.029_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1542\/peds.105.1.21","article-title":"Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study","volume":"105","author":"Schuchat","year":"2000","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2013.02.029_bib0145","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/adc.2008.148874","article-title":"Group B streptococcal disease in infants: a case control study","volume":"94","author":"Heath","year":"2009","journal-title":"Arch Dis Child"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.02.029_bib0150","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/INF.0b013e3181958780","article-title":"Antimicrobial resistance among neonatal pathogens in developing countries","volume":"28","author":"Thaver","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2013.02.029_bib0155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM199709183371209","article-title":"The ethics of clinical research in the Third World","volume":"337","author":"Angell","year":"1997","journal-title":"N Engl J Med"},{"issue":"9090","key":"10.1016\/j.vaccine.2013.02.029_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(97)26047-2","article-title":"Ethics of HIV trials","volume":"350","author":"Aaby","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.02.029_bib0165","unstructured":"Strategic Advisory Group of Experts (SAGE) on Immunization: http:\/\/wwwwhoint\/entity\/influenza\/vaccines\/SAGE_information\/en\/indexhtml 2012. Accessed 5 Jan 2013."},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.029_bib0170","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2013.02.029_bib0175","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"issue":"104","key":"10.1016\/j.vaccine.2013.02.029_bib0180","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/136.Supplement.S98","article-title":"Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus","volume":"136","author":"Baker","year":"1977","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.029_bib0185","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0022-3476(84)80564-8","article-title":"Transplacental passage of IgG antibody to group B streptococcus serotype Ia","volume":"104","author":"Boyer","year":"1984","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.029_bib0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.44.2.257-261.1984","article-title":"Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay","volume":"44","author":"Edwards","year":"1984","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.029_bib0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/322029","article-title":"Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate","volume":"184","author":"Davies","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.029_bib0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/338773","article-title":"Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum","volume":"185","author":"Lachenauer","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.029_bib0205","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1172\/JCI108703","article-title":"Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus","volume":"59","author":"Baker","year":"1977","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.029_bib0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1542\/peds.68.4.544","article-title":"Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection","volume":"68","author":"Baker","year":"1981","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.029_bib0215","first-page":"109","article-title":"Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns","volume":"90","author":"Suara","year":"1998","journal-title":"J Natl Med Assoc"},{"issue":"8","key":"10.1016\/j.vaccine.2013.02.029_bib0220","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.029_bib0225","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.029_bib0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/infdis\/148.4.648","article-title":"Estimation of the protective level of human IgG antibody to the type-specific polysaccharide of group B Streptococcus type Ia","volume":"148","author":"Klegerman","year":"1983","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.02.029_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clin.1997.4461","article-title":"Properties of human anti-group B streptococcal type III capsular IgG antibody","volume":"86","author":"Feldman","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"issue":"9705","key":"10.1016\/j.vaccine.2013.02.029_bib0240","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(09)61339-8","article-title":"Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial","volume":"374","author":"Cutland","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.029_bib0245","doi-asserted-by":"crossref","first-page":"e17861","DOI":"10.1371\/journal.pone.0017861","article-title":"Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads","volume":"6","author":"Madzivhandila","year":"2011","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T16:54:57Z","timestamp":1646412897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":49,"alternative-id":["S0264410X13001928"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}